Cleared Special

QuickVue Influenza A+B

K180288 · Quidel Corporation · Microbiology

Feb 2018

Decision

12d

Days

Class 2

Risk

About This 510(k) Submission

K180288 is an FDA 510(k) clearance for the QuickVue Influenza A+B, a Devices Detecting Influenza A, B, And C Virus Antigens (Class II — Special Controls, product code PSZ), submitted by Quidel Corporation (San Diego, US). The FDA issued a Cleared decision on February 13, 2018, 12 days after receiving the submission on February 1, 2018. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3328.

Submission Details

510(k) Number	K180288 FDA.gov
FDA Decision	Cleared SESE
Date Received	February 01, 2018
Decision Date	February 13, 2018
Days to Decision	12 days
Submission Type	Special
Review Panel	Microbiology (MI)
Summary	Summary PDF

Device Classification

Product Code	PSZ — Devices Detecting Influenza A, B, And C Virus Antigens
Device Class	Class II — Special Controls
CFR Regulation	21 CFR 866.3328
Definition	An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection.